|
⚲
|
| Keyboard |
| Clayton Duncan | |
|---|---|
| Firm | |
| Address | c/o Valanbio Therapeutics, Inc 1120 Longstone Way Raleigh, NC 27614 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Valanbio Therapeutics Inc | 021-348130 | Executive Officer | 0.4 M of 0.6 M |
||
| Synereca Pharmaceuticals Inc | 021-292834 | Executive Officer | 0.6 M of 1.2 M |
||
| Accele Biopharma Inc | 021-183577 | Executive Officer | 2.6 M of 2.6 M |
||
| Accele Venture Partners I LP | 021-182183 | Executive Officer | 10.0 M of 20.0 M |
||
| Neuronex Inc | 021-159369 | Executive Officer | 0.4 M of 1.2 M |
||
| Synereca Pharmaceuticals Inc | 021-155000 | Director | 0.3 M of 0.3 M |
||
| Neuronex Inc | 021-147421 | Director | 0.8 M of 1.4 M |
||